Literature DB >> 2722061

Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix.

C W Drescher1, M P Hopkins, J A Roberts.   

Abstract

Retrospective review of medical records and autopsy findings in patients dying of squamous cell cancer or adenocarcinoma of the uterine cervix was undertaken to evaluate for possible differences in biologic behavior between these tumor types. Twenty-one patients with each tumor type were evaluated. Patients with adenocarcinoma were found to have a higher incidence of tumor involvement of the paraaortic lymph nodes (13/21 vs 6/20, P less than 0.05), uterine corpus (17/17 vs 12/20, P less than 0.05), and adrenal gland (7/21 vs 0/21, P less than 0.005). Presence of ascites (9/21 vs 2/21, P less than 0.05) and hydrothorax (9/21 vs 3/21, P less than 0.05) was also significantly more frequent in patients with adenocarcinoma. These findings suggest that this tumor may behave differently in regard to pattern of metastatic spread or response to therapy. The therapeutic implications of these findings deserve further study.

Entities:  

Mesh:

Year:  1989        PMID: 2722061     DOI: 10.1016/0090-8258(89)90524-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Infratemporal fossa metastasis from carcinoma of the uterine cervix.

Authors:  Ioannis Dimitrakopoulos; Aris Ntomouchtsis; Fotis Iordanidis
Journal:  Oral Maxillofac Surg       Date:  2011-06

2.  Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix.

Authors:  J-Y Park; D-Y Kim; J-H Kim; Y-M Kim; Y-T Kim; J-H Nam
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

3.  Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.

Authors:  Anil K Chaturvedi; Ruth A Kleinerman; Allan Hildesheim; Ethel S Gilbert; Hans Storm; Charles F Lynch; Per Hall; Froydis Langmark; Eero Pukkala; Magnus Kaijser; Michael Andersson; Sophie D Fossa; Heikki Joensuu; Lois B Travis; Eric A Engels
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

Review 4.  Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.

Authors:  Astrid Baalbergen; Yerney Veenstra; Lukas Stalpers
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

5.  Bone involvement by adenocarcinoma of the uterine cervix: a rare entity.

Authors:  Vincenzina Crisci; Pier Paolo Mainenti; Fabio Corvino; Rossella Lauria; Simone Maurea
Journal:  Pol J Radiol       Date:  2015-02-14

6.  Changing the Prognosis of Metastatic Cervix Uteri Adenosquamous Carcinoma through a Multimodal Approach: A Case Report.

Authors:  Mihai Teodor Georgescu; Dragos Eugen Georgescu; Teodor Florin Georgescu; Luiza Georgia Serbanescu
Journal:  Case Rep Oncol       Date:  2020-12-23

7.  SOX1 and PAX1 Are Hypermethylated in Cervical Adenocarcinoma and Associated with Better Prognosis.

Authors:  Zitong Zhao; Xiaoye Zhang; Xueheng Zhao; Jingting Cai; Na-Yi Yuan Wu; Jing Wang
Journal:  Biomed Res Int       Date:  2020-12-07       Impact factor: 3.411

8.  Comparison of Outcomes and Prognostic Factors Between Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma Patients After Radical Surgery and Postoperative Adjuvant Radiotherapy.

Authors:  Yuncan Zhou; Weiping Wang; Ke Hu; Fuquan Zhang
Journal:  Cancer Manag Res       Date:  2021-10-04       Impact factor: 3.989

9.  Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.

Authors:  T Kasamatsu; T Onda; M Sawada; T Kato; S Ikeda; Y Sasajima; H Tsuda
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  Cervical carcinoma manifesting as progressive bilateral visual loss.

Authors:  O'Sam Shibeeb; Paul Athanasiov; Sumu Simon; Jagjit Gilhotra
Journal:  Case Rep Ophthalmol Med       Date:  2014-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.